Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Weichang ZHOU
Weichang ZHOU
Positions:

Chief Technology Officer, Executive Vice President, Biologics Development and Manufacturing

Company:

WuXi Biologics

Dr. Weichang Zhou is Executive Director of the Board, Executive Vice President and Chief Technology Officer (CTO) of WuXi Biologics. With more than 25 years of industry experience, Dr. Zhou provides strategic leadership to the firm as he leads a biologics development team of more than 2,500 employees supported by over 200 experienced scientists – recognized as one of the five largest biological development teams in the world. Dr. Zhou specializes in biologics manufacturing process development, scale-up, characterization, technology transfer, manufacturing and regulatory support.

 

Prior to joining WuXi Biologics in 2012, Dr. Zhou served in senior leadership positions with multiple Chemistry, Manufacturing, and Controls (CMC) teams, including as Senior Director of Commercial Cell Culture Development at Genzyme (a Sanofi company), Senior Director of Process Sciences and Engineering at PDL BioPharma, and Associate Director of Fermentation and Cell Culture at Merck.

 

Dr. Zhou has authored and published over 50 scientific papers and holds several patents. He has delivered over 200 presentations and lectures at multiple international conferences and professional courses, and is active in organizing and chairing conferences and symposia related to the development and commercialization of vaccines and biologics. Dr. Zhou served as Chair of the Cell Culture Engineering (XIV) 2014 Conference, Biochemical Engineering (XIII) 2003 Conference, and 2004 Program of the Division of Biochemical Technology of the American Chemical Society (ACS) at the 227th ACS Spring National Meeting. Dr. Zhou was elected as an American Chemical Society fellow in 2013 and an American Institute for Medical and Biological Engineering (AIMBE) fellow in 2002. He previously served as an executive committee member of the Division of Biochemical Technology (BIOT) at the American Chemical Society between 2003 and 2014. He also served as the Division’s Program Chair (2004), Awards Chair (2005-2008), Chair-Elect (2008), Chair (2009) and Past-Chair (2010).

 

Dr. Zhou obtained a Ph.D. in Chemical Engineering from the University of Hannover in 1989 and conducted postdoctoral research at the German Association of Chemical Engineering and Biotechnology, Swiss Federal Institute of Technology Zurich, and the University of Minnesota.